Depletion of MGO or Its Derivatives Ameliorate CUMS-Induced Neuroinflammation
Open Access
Abstract
Advanced glycation end products (AGEs) are a series of structurally complex and harmful compounds formed through the reaction between the carbonyl group of reducing sugars (such as glucose and fructose) and the free amino groups of proteins, lipids, or nucleic acids. Excessive accumulation of AGEs in the body can trigger oxidative stress, induce inflammatory responses, and contribute to the development of diabetes, atherosclerosis, and neurological disorders. Within the category of dicarbonyl compounds, methylglyoxal (MGO)—a byproduct resulting from glucose degradation—serves as a pivotal precursor in the formation of AGEs and the induction of neurotoxicity. Specifically, AGEs generated from MGO display significant cytotoxicity toward cells in the central nervous system. Therefore, we aimed to investigate the role of MGO-AGEs in neuroinflammation mediated by CUMS. Interestingly, we found that the overexpression of glyoxalase 1 (GLO1) reduced the levels of MGO in corticosterone-treated microglia, thereby alleviating the inflammatory response. Furthermore, overexpression of GLO1 in the hippocampus of chronically stressed mice reduced MGO levels, mitigating CUMS-induced neuroinflammation and cognitive impairment. Additionally, when using the receptor for advanced glycation end products (RAGE) inhibitor FPS-ZM1 in primary microglia cells, we observed that despite corticosterone-induced elevation of MGO, no significant inflammatory response occurred. This suggests that RAGE clearance can reduce MGO-AGE-mediated neurotoxicity. Subsequently, we used FPS-ZM1 to treat chronically stressed mice and found that it significantly ameliorated neuroinflammation and cognitive dysfunction. These results suggest that targeting MGO metabolism could serve as a therapeutic approach to manage neuroinflammation in stress-related mental disorders.Keywords
Funding Information
- National Natural Science Foundation of China (82271553, 82201685)
This publication has 54 references indexed in Scilit:
- Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implicationsActa Pharmaceutica Sinica B, 2024
- Stress, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, and aggressionMetabolic Brain Disease, 2024
- Pivotal role of AGE-RAGE axis in brain aging with current interventionsAgeing Research Reviews, 2024
- Blood-brain barrier dysfunction mediated by the EZH2-Claudin-5 axis drives stress-induced TNF-α infiltration and depression-like behaviorsBrain, Behavior, and Immunity, 2023
- The Metaflammatory and Immunometabolic Role of Macrophages and Microglia in Diabetic RetinopathyHuman Cell, 2021
- Train to Lose: Innate Immune Memory in MetaflammationMolecular Nutrition & Food Research, 2020
- Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depressionBehavioural Brain Research, 2019
- RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary MicrogliaNeurochemical Research, 2017
- Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat HippocampusNeurochemical Research, 2016
- Methylglyoxal-induced cytotoxicity in neonatal rat brain: a role for oxidative stress and MAP kinasesMetabolic Brain Disease, 2013